Die Zweckmäßigkeit der arzneimittelrechtlichen Gefährdungshaftung

Valsartan und die Folgen
Nomos, 1. Edition 2021, 282 Pages
The product is part of the series Nomos Universitätsschriften – Recht
Book
€79.00
ISBN 978-3-8487-8373-1
eBook
€79.00
ISBN 978-3-7489-2764-8
Available
Prices include VAT. Depending on the delivery address, VAT may vary at checkout.
Description
In this doctoral thesis, the medicinal product law strict liability from § 84 AMG is evaluated with regard to its expediency. First, the institute of strict liability is comprehensively explained. The focus of the work is the problem of proving causality.
It becomes clear in the work that even the presumption of causality from § 84 para. 2 AMG does not solve the problems of proof. The author argues for a lowering of the standard of proof and cites European law arguments for this. In the author's opinion, the presumption of causality from § 84 Para. 2 AMG contradicts the European Product Liability Directive, which, in the author's opinion, must guide medicinal product liability.
Bibliographical data
Bibliographical data
Edition 1
ISBN 978-3-8487-8373-1
Subtitle Valsartan und die Folgen
Publication Date Oct 1, 2021
Year of Publication 2021
Publisher Nomos
Format Softcover
Language deutsch
Pages 282
Medium Book
Product Type Scientific literature
Additional material
Product safety information

Manufacturer of products offered under GPSR

Nomos Verlagsgesellschaft mbH & Co. KG
Waldseestraße 3 - 5
76530 Baden-Baden, Germany

service@nomos.de
www.nomos.de

© 2025 Nomos Verlagsgesellschaft mbH & Co. KG